Peptydy

• Cayman | 200 µg | 10004457-1 | 15-Lipoxygenase-2 Blocking Peptide
• Cayman | 200 µg | 10004884-1 | CRTH2/DP2 Receptor (N-Term) Blocking Peptide
• Cayman | 1 ea | 10005729-1 | 11β-Hydroxysteroid Dehydrogenase (Type 1) Blocking Peptide
• Cayman | 1 ea | 10006591-1 | CB1 Receptor (C-Term) Blocking Peptide
• Cayman | 1 ea (500 µl) | 10006778-1 | Nitrotyrosine (Peptide) Polyclonal Antibody
• Cayman | 1 ea | 10006823-1 | Sphingosine Kinase 1 Blocking Peptide
• Cayman | 1 ea | 10006984-1 | LPA1 Blocking Peptide
• Cayman | 1 ea | 10007193-1 | Autotaxin Blocking Peptide
• Cayman | 1 ea | 10007672-1 | LDL Receptor Blocking Peptide
• Cayman | 1 ea | 10009333-1 | HAT Peptide
• Cayman | 1 ea | 10010995-1 | SIRT1 Peptide
• Cayman | 1 ea | 10011082-1 | SIRT1 FRET Peptide
• Cayman | 1 ea | 10012542-1 | SIRT3 Direct Peptide
• Cayman | 200 µg | 10225-1 | GPR55 Blocking Peptide
• Cayman | 1 mg | 10228-1 | TAF 10 Peptide
• Cayman | 200 µg | 10303-1 | NAPE-PLD Blocking Peptide (aa 159-172)
• Cayman | 200 µg | 10326-1 | Chemokine-Like Receptor 1 Blocking Peptide
• Cayman | 1 mg | 10380-1 | Histone H4 Peptide Substrate (15-24)
• Cayman | 5 mg | 10380-5 | Histone H4 Peptide Substrate (15-24)
• Cayman | 100 mg | 10526-100 | Myristoyl Pentapeptide-17 (trifluoroacetate salt)
• Cayman | 25 mg | 10526-25 | Myristoyl Pentapeptide-17 (trifluoroacetate salt)
• Cayman | 50 mg | 10526-50 | Myristoyl Pentapeptide-17 (trifluoroacetate salt)
• Cayman | 500 mg | 10526-500 | Myristoyl Pentapeptide-17 (trifluoroacetate salt)
• Cayman | 1 mg | 10530-1 | Histone H3 Trimethyl Lys9 Peptide
• Cayman | 1 mg | 10854-1 | Histone H4 Peptide Substrate (1-21)
• Cayman | 1 mg | 10877-1 | Histone H3 Peptide Substrate (1-21) (trifluoroacetate salt)
• Cayman | 25 mg | 11188-25 | Prolyl-glycyl-proline Peptide
• Cayman | 5 mg | 11188-5 | Prolyl-glycyl-proline Peptide
• Cayman | 25 mg | 11189-25 | N-acetyl-Pro-Gly-Pro Peptide
• Cayman | 5 mg | 11189-5 | N-acetyl-Pro-Gly-Pro Peptide
• Cayman | 1 mg | 14501-1 | RGD Peptide (trifluoroacetate salt)
• Cayman | 10 mg | 14501-10 | RGD Peptide (trifluoroacetate salt)
• Cayman | 25 mg | 14501-25 | RGD Peptide (trifluoroacetate salt)
• Cayman | 5 mg | 14501-5 | RGD Peptide (trifluoroacetate salt)
• Cayman | 1 mg | 15071-1 | Neuropeptide Y (human, rat)
• Cayman | 5 mg | 15071-5 | Neuropeptide Y (human, rat)
• Cayman | 500 µg | 15071-500 | Neuropeptide Y (human, rat)
• Cayman | 10 mg | 15359-10 | RGDS Peptide (trifluoroacetate salt)
• Cayman | 25 mg | 15359-25 | RGDS Peptide (trifluoroacetate salt)
• Cayman | 5 mg | 15359-5 | RGDS Peptide (trifluoroacetate salt)
• Cayman | 50 mg | 15359-50 | RGDS Peptide (trifluoroacetate salt)
• Cayman | 1 mg | 16502-1 | Peptide YY (3-36) (trifluoroacetate salt)
• Cayman | 500 µg | 16502-500 | Peptide YY (3-36) (trifluoroacetate salt)
• Cayman | 1 mg | 17061-1 | SAMS Peptide
• Cayman | 5 mg | 17061-5 | SAMS Peptide
• Cayman | 500 µg | 17061-500 | SAMS Peptide
• Cayman | 1 mg | 17474-1 | Ras Inhibitory Peptide
• Cayman | 10 mg | 17474-10 | Ras Inhibitory Peptide
• Cayman | 5 mg | 17474-5 | Ras Inhibitory Peptide
• Cayman | 500 µg | 17474-500 | Ras Inhibitory Peptide